UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Hepatology (Baltimore, Md.), 2019-01, Vol.69 (1), p.394-419

2019

Volltextzugriff (PDF)

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Hepatology (Baltimore, Md.), 2022-04, Vol.75 (4), p.1012-1013

2022

Volltextzugriff (PDF)

Primary biliary cirrhosis

The Lancet (British edition), 2011-05, Vol.377 (9777), p.1600-1609

2011

Volltextzugriff (PDF)

IL‐12/Th1 and IL‐23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy

Hepatology (Baltimore, Md.), 2014-05, Vol.59 (5), p.1944-1953

2014

Volltextzugriff (PDF)

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012

World journal of gastroenterology : WJG, 2016-10, Vol.22 (38), p.8584-8595

2016

Volltextzugriff (PDF)

Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature

Journal of autoimmunity, 2019-07, Vol.101, p.26-34

2019

Volltextzugriff (PDF)

The evolution of natural history of primary sclerosing cholangitis

Current opinion in gastroenterology, 2017-03, Vol.33 (2), p.71-77

2017

Volltextzugriff (PDF)

Reply: Living donor liver transplantation for people with PSC

Hepatology (Baltimore, Md.), 2023-05, Vol.77 (5), p.E97-E98

2023

Volltextzugriff (PDF)

Biliary apotopes and anti‐mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

Hepatology (Baltimore, Md.), 2010-09, Vol.52 (3), p.987-998

2010

Volltextzugriff (PDF)

The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis

Cellular & molecular immunology, 2017-03, Vol.14 (3), p.276-284

2017

Volltextzugriff (PDF)

Diagnosis and classification of primary sclerosing cholangitis

Autoimmunity reviews, 2014-04, Vol.13 (4), p.445-450

2014

Volltextzugriff (PDF)

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

BMC gastroenterology, 2011-07, Vol.11 (1), p.83-83, Article 83

2011

Volltextzugriff (PDF)

Ongoing activation of autoantigen‐specific B cells in primary biliary cirrhosis

Hepatology (Baltimore, Md.), 2014-11, Vol.60 (5), p.1708-1716

2014

Volltextzugriff (PDF)

Primary sclerosing cholangitis: A review and update

Liver research, 2017-12, Vol.1 (4), p.221-230

2017

Volltextzugriff (PDF)

Development and validation of a primary sclerosing cholangitis–specific patient‐reported outcomes instrument: The PSC PRO

Hepatology (Baltimore, Md.), 2018-07, Vol.68 (1), p.155-165

2018

Volltextzugriff (PDF)

The immunobiology of primary sclerosing cholangitis

Seminars in immunopathology, 2009-09, Vol.31 (3), p.383-397

2009

Volltextzugriff (PDF)

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis

BMC gastroenterology, 2023-03, Vol.23 (1), p.75-75, Article 75

2023

Volltextzugriff (PDF)

Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis

Frontiers in immunology, 2022-08, Vol.13, p.912961-912961

2022

Volltextzugriff (PDF)

Optimizing treatment of primary biliary cholangitis: Is good, good enough?

Hepatology (Baltimore, Md.), 2024-01, Vol.79 (1), p.3-5

2024

Volltextzugriff (PDF)

Incidence and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis

Clinical reviews in allergy & immunology, 2015-06, Vol.48 (2-3), p.132-141

2015

Volltextzugriff (PDF)

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis

Liver international, 2015-02, Vol.35 (2), p.642-651

2015

Volltextzugriff (PDF)

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

Clinical therapeutics, 2007, Vol.29 (1), p.139-153

2007

Volltextzugriff (PDF)

AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review

Clinical gastroenterology and hepatology, 2019-11, Vol.17 (12), p.2416-2422

2019

Volltextzugriff (PDF)

Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC)

Autoimmunity reviews, 2016-08, Vol.15 (8), p.795-800

2016

Volltextzugriff (PDF)

Advances in pharmacotherapy for primary biliary cirrhosis

Expert opinion on pharmacotherapy, 2015-04, Vol.16 (5), p.633-643

2015

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(218)

Publikationsform

Artikel
(244)
Buchkapitel
(15)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Primary biliary cirrhosis

IL‐12/Th1 and IL‐23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012

Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature

The evolution of natural history of primary sclerosing cholangitis

Reply: Living donor liver transplantation for people with PSC

Biliary apotopes and anti‐mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis

Diagnosis and classification of primary sclerosing cholangitis

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

Ongoing activation of autoantigen‐specific B cells in primary biliary cirrhosis

Primary sclerosing cholangitis: A review and update

Development and validation of a primary sclerosing cholangitis–specific patient‐reported outcomes instrument: The PSC PRO

The immunobiology of primary sclerosing cholangitis

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis

Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis

Optimizing treatment of primary biliary cholangitis: Is good, good enough?

Incidence and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review

Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC)

Advances in pharmacotherapy for primary biliary cirrhosis

Suchergebnisse filtern